COVID-19: 122,410 Nigerians vaccinated 18-days after vaccine launch
At least 122,410 people have so far been vaccinated with the Oxford AstraZeneca jabs in Nigeria since the commencement of the exercise on March 5, 2021.
This was disclosed by the Executive Director of the National Primary Healthcare Development Agency (NPHCDA), Dr. Faisal Shuaib at the briefing of the Presidential Task Force (PTF) on COVID-19 in Abuja.
Shuaib clarified that no Nigerian had developed any reported severe side effect except some mild symptoms like pain and swelling at the site of the vaccination in addition to body pains and little fever.
He said full vaccination of eligible Nigerians was done in 32 states with only exception of Kogi, Kebbi, Zamfara and Oyo.
It has also struck a partnership with regulatory and anti-corruption agencies to strengthen accountability besides putting in place mechanisms to ensure seamless vaccine rollout across the federation.
He said: “At this stage it is important to address Nigerians that so far 122,410 people have been vaccinated with the Oxford-AstraZeneca vaccine in Nigeria.
“Available records from the vaccination site do not indicate any serious adverse events following immunization from the ongoing covid-19 vaccination exercise since its national launch on the 5th of March 2021.
“No Nigerian so far has developed any known severe side effects following vaccination with the AstraZeneca vaccine.
“While we have observed among some vaccines the mild symptoms such as pain and swelling at the site of the vaccination, body pains, and mild fever, it is important to note that it is possible for you to take the vaccine and have other diseases that are completely unrelated to the vaccination process.
“We shall continue to collaborate with the NAFDAC pharmacovigilance team to monitor the administration of the vaccine and document any adverse reactions following the vaccination with covid-19 vaccines.
“As of today, full implementation of the COVID-19 vaccination of eligible population has commenced in 33 states and the FCT, while four states – Kogi, Kebbi, Zamfara and Oyo states are yet to commence implementation.”
“I am aware that Kebbi state will be flagging off the vaccination program today by 3pm yesterday. We are yet to get confirmation of that though.”
Shuaib observed that the PTF was closely monitoring vaccine accountability in all states to check mismanagement adding that the results from the long awaited U.S. trial of the vaccine confirmed that it is both safe and highly effective.
Speaking on the mismanagement of the vaccine, Shuaib said “We shall continue to collaborate with the NAFDAC’s Pharmacovigilance team to monitor the administration of the vaccine and document any adverse reaction with COVID-19 vaccine to assure Nigerians that government is honest and transparent in its choice of this vaccine for the purpose of protecting the citizens against COVID-19.
“Some of the information reaching us from the states is that there are reports of alleged vaccine mismanagement in some vaccination sites like the one reported at the Police Clinic, Falomo in Lagos State. The matter is being investigated and the report will be made public. We anticipate that decisive actions will be taken against anyone found culpable of subverting the vaccination process in the country.”
SPEECH BY DR FAISAL SHUAIB, EXECUTIVE DIRECTOR/CEO OF THE NATIONAL PRIMARY HEALTH CARE DEVELOPMENT AGENCY (NPHCDA) AT THE WEEKLY NATIONAL BRIEFING OF THE COVID-19 PRESIDENTIAL TASK FORCE ON MONDAY 22ND March 2021 IN ABUJA
— NPHCDA (@NphcdaNG) March 22, 2021